Chinese Spondyloarthritis Inception Cohort (CESPIC)

Launched by SOUTHWEST HOSPITAL, CHINA · Jul 25, 2023

Keywords

ClinConnect Summary

The Chinese Spondyloarthritis Inception Cohort (CESPIC) is a study that aims to better understand early forms of spondyloarthritis (SpA), which includes conditions like ankylosing spondylitis and axial psoriatic arthritis. Researchers want to see how these diseases progress over time, identify factors that may predict outcomes, and evaluate how they affect patients' quality of life and costs associated with treatment. The study is currently not recruiting participants, but it will include individuals with conditions like Crohn's disease, acute anterior uveitis, and reactive arthritis.

To participate in this study, potential participants should have one of the specific conditions related to spondyloarthritis. However, individuals with infections, cancer, or serious heart issues will not be eligible. Participants can expect to be monitored over several years, providing valuable information that could help improve treatment and understanding of these conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Crohn's disease. Acute anterior uveitis. Psoriatic arthritis with axial involvement. Reactive arthritis.
• Exclusion Criteria:
• • Infections, Malignancies, Major cardiovascular events, Lower intestinal perforations Other adverse events